About us Pricing ContactSubscribe

J

James Chih‐Hsin Yang

National Taiwan University HospitalORCID https://orcid.org/0000-0002-5586-5138

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

New England Journal of Medicine20098,201 citations

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

Journal of Clinical Oncology20133,181 citations

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Clinical Cancer Research20112,095 citations

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

The Lancet Oncology20151,573 citationsFirst authorCorresponding

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

The Lancet Oncology20161,385 citations

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

Annals of Surgery19891,007 citations

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Clinical Cancer Research2014781 citations

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

Annals of Surgical Oncology2005489 citations

James Chih‐Hsin Yang · Scinovex